165 related articles for article (PubMed ID: 26749169)
21. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
Timmins JM; Lee JY; Boudyguina E; Kluckman KD; Brunham LR; Mulya A; Gebre AK; Coutinho JM; Colvin PL; Smith TL; Hayden MR; Maeda N; Parks JS
J Clin Invest; 2005 May; 115(5):1333-42. PubMed ID: 15841208
[TBL] [Abstract][Full Text] [Related]
22. Tangier disease and ABCA1.
Oram JF
Biochim Biophys Acta; 2000 Dec; 1529(1-3):321-30. PubMed ID: 11111099
[TBL] [Abstract][Full Text] [Related]
23. Endocytosis is enhanced in Tangier fibroblasts: possible role of ATP-binding cassette protein A1 in endosomal vesicular transport.
Zha X; Genest J; McPherson R
J Biol Chem; 2001 Oct; 276(42):39476-83. PubMed ID: 11504722
[TBL] [Abstract][Full Text] [Related]
24. Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1.
Oram JF
Trends Mol Med; 2002 Apr; 8(4):168-73. PubMed ID: 11927274
[TBL] [Abstract][Full Text] [Related]
25. Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia.
Slatter TL; Williams MJ; Frikke-Schmidt R; Tybjaerg-Hansen A; Morison IM; McCormick SP
Atherosclerosis; 2006 Aug; 187(2):393-400. PubMed ID: 16225879
[TBL] [Abstract][Full Text] [Related]
26. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency.
Christiansen-Weber TA; Voland JR; Wu Y; Ngo K; Roland BL; Nguyen S; Peterson PA; Fung-Leung WP
Am J Pathol; 2000 Sep; 157(3):1017-29. PubMed ID: 10980140
[TBL] [Abstract][Full Text] [Related]
27. ABCA1. The gatekeeper for eliminating excess tissue cholesterol.
Oram JF; Lawn RM
J Lipid Res; 2001 Aug; 42(8):1173-9. PubMed ID: 11483617
[TBL] [Abstract][Full Text] [Related]
28. Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C.
Cameron J; Ranheim T; Halvorsen B; Kulseth MA; Leren TP; Berge KE
Atherosclerosis; 2010 Mar; 209(1):163-6. PubMed ID: 19765707
[TBL] [Abstract][Full Text] [Related]
29. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
Gross PL; Rand ML; Barrow DV; Packham MA
Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
[TBL] [Abstract][Full Text] [Related]
30. Targeted deletion of hepatocyte ABCA1 leads to very low density lipoprotein triglyceride overproduction and low density lipoprotein hypercatabolism.
Chung S; Timmins JM; Duong M; Degirolamo C; Rong S; Sawyer JK; Singaraja RR; Hayden MR; Maeda N; Rudel LL; Shelness GS; Parks JS
J Biol Chem; 2010 Apr; 285(16):12197-209. PubMed ID: 20178985
[TBL] [Abstract][Full Text] [Related]
31. Double deletions and missense mutations in the first nucleotide-binding fold of the ATP-binding cassette transporter A1 ( ABCA1) gene in Japanese patients with Tangier disease.
Guo Z; Inazu A; Yu W; Suzumura T; Okamoto M; Nohara A; Higashikata T; Sano R; Wakasugi K; Hayakawa T; Yoshida K; Suehiro T; Schmitz G; Mabuchi H
J Hum Genet; 2002; 47(6):325-9. PubMed ID: 12111381
[TBL] [Abstract][Full Text] [Related]
32. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins.
Oram JF; Vaughan AM
Curr Opin Lipidol; 2000 Jun; 11(3):253-60. PubMed ID: 10882340
[TBL] [Abstract][Full Text] [Related]
33. Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency.
Nishida Y; Hirano K; Tsukamoto K; Nagano M; Ikegami C; Roomp K; Ishihara M; Sakane N; Zhang Z; Tsujii Ki K; Matsuyama A; Ohama T; Matsuura F; Ishigami M; Sakai N; Hiraoka H; Hattori H; Wellington C; Yoshida Y; Misugi S; Hayden MR; Egashira T; Yamashita S; Matsuzawa Y
Biochem Biophys Res Commun; 2002 Jan; 290(2):713-21. PubMed ID: 11785958
[TBL] [Abstract][Full Text] [Related]
34. Novel mutations in ABCA1 gene in Japanese patients with Tangier disease and familial high density lipoprotein deficiency with coronary heart disease.
Huang W; Moriyama K; Koga T; Hua H; Ageta M; Kawabata S; Mawatari K; Imamura T; Eto T; Kawamura M; Teramoto T; Sasaki J
Biochim Biophys Acta; 2001 Jul; 1537(1):71-8. PubMed ID: 11476965
[TBL] [Abstract][Full Text] [Related]
35. A novel ABCA1 nonsense mutation, R1270X, in Tangier disease associated with an unrecognised bleeding tendency.
Hooper AJ; Robertson K; Ng L; Kattampallil JS; Latchem D; Willsher PC; Thom J; Baker RI; Burnett JR
Clin Chim Acta; 2009 Nov; 409(1-2):136-9. PubMed ID: 19723515
[TBL] [Abstract][Full Text] [Related]
36. Tangier disease may cause early onset of atherosclerotic cerebral infarction: A case report.
Liang Z; Li W; Yang S; Liu Z; Sun X; Gao X; Yu G
Medicine (Baltimore); 2018 Sep; 97(39):e12472. PubMed ID: 30278532
[TBL] [Abstract][Full Text] [Related]
37. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.
Mott S; Yu L; Marcil M; Boucher B; Rondeau C; Genest J
Atherosclerosis; 2000 Oct; 152(2):457-68. PubMed ID: 10998475
[TBL] [Abstract][Full Text] [Related]
38. Plasma amyloid-β in patients with Tangier disease.
Shahim P; Bochem AE; Mattsson N; Lautner R; Blennow K; Hovingh GK; Motazacker MM; Zetterberg H
J Alzheimers Dis; 2013; 35(2):307-12. PubMed ID: 23388172
[TBL] [Abstract][Full Text] [Related]
39. The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease.
Jacobo-Albavera L; Domínguez-Pérez M; Medina-Leyte DJ; González-Garrido A; Villarreal-Molina T
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562440
[TBL] [Abstract][Full Text] [Related]
40. A novel missense mutation of ABCA1 in transmembrane alpha-helix in a Japanese patient with Tangier disease.
Maekawa M; Kikuchi J; Kotani K; Nagao K; Odgerel T; Ueda K; Kawano M; Furukawa Y; Sakurabayashi I
Atherosclerosis; 2009 Sep; 206(1):216-22. PubMed ID: 19344898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
